Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-3,306
Closed -$258K – 732
2022
Q2
$258K Sell
3,306
-846
-20% -$69.9K 0.01% 470
2022
Q1
$354K Buy
+4,152
New +$398K 0.01% 381
2020
Q3
– Sell
-442
Closed -$29K – 861
2020
Q2
$29K Sell
442
-62
-12% -$4.09K ﹤0.01% 320
2020
Q1
$33K Buy
504
+223
+79% +$17.6K ﹤0.01% 218
2019
Q4
$22K Hold
281
– – ﹤0.01% 288
2019
Q3
$22K Hold
281
– – ﹤0.01% 227
2019
Q2
$24K Hold
281
– – ﹤0.01% 193
2019
Q1
$22K Hold
281
– – ﹤0.01% 199
2018
Q4
$19K Hold
281
– – ﹤0.01% 199
2018
Q3
$22K Buy
+281
New +$21K ﹤0.01% 135
2018
Q1
– Sell
-740
Closed -$50K – 536
2017
Q4
$50K Sell
740
-240
-24% -$15.9K ﹤0.01% 274
2017
Q3
$61K Hold
980
– – 0.01% 243
2017
Q2
$54K Hold
980
– – ﹤0.01% 237
2017
Q1
$49K Hold
980
– – ﹤0.01% 224
2016
Q4
$49K Buy
980
+230
+31% +$11.7K 0.01% 210
2016
Q3
$39K Hold
750
– – 0.01% 197
2016
Q2
$33K Hold
750
– – 0.01% 199
2016
Q1
$31K Hold
750
– – 0.01% 146
2015
Q4
$27K Buy
+750
New +$27.1K 0.01% 220

Other funds holding XYL

Balentine LLC's XYL Position: Q3 2022 in Review

Balentine LLC sold out of Xylem (XYL) in Q3 2022, closing a stake of 3,306 shares — an estimated $258K sold.

Balentine LLC first reported a position in XYL in Q4 2015 and held it in 19 quarters. The position peaked at $354K in Q1 2022. 741 funds tracked by Wall St. Rank hold XYL as of Q3 2022.

  • Balentine LLC reported no remaining Xylem position as of Q3 2022 after selling out during the quarter.
  • Balentine LLC sold 3,306 Xylem shares in Q3 2022, an estimated $258K.
  • Balentine LLC first reported a position in Xylem in Q4 2015 and held it in 19 quarters.
  • Balentine LLC's Xylem position peaked at $354K in Q1 2022.
  • 741 funds tracked by Wall St. Rank held Xylem as of Q3 2022.

Based on Balentine LLC's 13F filing for Q3 2022, filed 26 Oct 2022.